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Abstract
Background: The aim of this study was to prove the relationship between the intraocular straylight level and diabetic
retinopathy (DR) according to disease severity. Also, we aimed to evaluate whether diabetes mellitus (DM) per se could
be a risk factor of increased intraocular straylight although we did not rely on a definite sign of DR in this study.
Methods: In this prospective comparative study, ninety three eyes were enrolled and divided into four groups as
follows: Group 1 (26 eyes), without DR or DM; Group 2 (25 eyes), with DM but without DR; Group 3 (21 eyes), mild to
moderate non-proliferative DR; and Group 4 (21 eyes), severe non-proliferative DR. To measure the intraocular straylight
in an objective manner, the C-quant straylight meter was used to preoperatively and 2 months postoperatively in all
patients who underwent phacoemulsification surgery. All the patients also underwent a macular optical coherence
tomography and hemoglobin A1c (HbA1c) analysis. A comparison of straylight levels adjusted by age among four
groups was performed postoperatively.
Results: The postoperative level of intraocular straylight was statistically significantly different among four
groups (P <0.05). When adjusted for ages, Group 4 showed the highest straylight level when compared with
Group 3 and the other two groups (P <0.05). Group 1 showed the lowest straylight level in comparison with
Group 2 and the other two groups (P <0.05). There was no significant correlation between HbA1c level,
duration of diabetes and postoperative straylight level.
Conclusions: The level of intraocular straylight at 2 months postoperatively had a tendency to increase as the severity
of DR increased. Additionally, the straylight level was higher in DM patients without DR than in patients without DM.
Therefore, the severity of DR seemed to influence the intraocular straylight level. Although there is no definite sign of
DR, DM per se can be a risk factor for increasing intraocular straylight. In conclusion, the level of intraocular straylight
seems to be a sensitive test for detecting early retinal damage secondary to DM.
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Background
In an ideal eye, light scattering should be absent. Be-
cause the optical media of the human eye is not ideal
optically, a certain amount of light scattering always oc-
curs. This light scattering is called intraocular straylight
[1]. Patients with straylight complain of the following
symptoms: increased glare sensitivity, reduced ability to
perceive contrasts in light or color, and haziness of vi-
sion. Thus, intraocular straylight can decrease the
amount of contrast between the perceived image of an
object and the surrounding image. Based on the com-
pensation comparison method, a straylight meter
(Oculus C-Quant, Oculus GmbH) can be used to deter-
mine the level of intraocular straylight. In this device,
absolute straylight level is expressed as log (straylight
parameter), or log(s).
Within the normal eye, the following five ocular struc-
tures contribute to the intraocular straylight: the cornea,
iris, sclera, lens and retinal fundus [2]. Optical clarity is
a fundamental property of the cornea. Therefore, corneal
haze with decreased corneal transparency is related to
increased light scattering [3]. Corneal factors such as
corneal edema [4], dry eye [3] and corneal refractive sur-
gery [5, 6], are associated with changes in intraocular
* Correspondence: eyedoc@catholic.ac.kr
2Postal address: Department of Ophthalmology and Visual Science, St. Paul’s
Hospital, College of Medicine, The Catholic University of Korea, 222
Banpo-daero, Seocho-gu, Seoul 137-701, Republic of Korea
Full list of author information is available at the end of the article
© 2015 Hwang et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Hwang et al. BMC Ophthalmology  (2015) 15:130 
DOI 10.1186/s12886-015-0120-1
straylight. Additionally, factors associated with the crys-
talline lens [7] and intraocular lens (IOL) [8, 9] are re-
lated with changes in straylight. However, there is a lack
of studies demonstrating the effect of retinal disorders
on intraocular straylight. Some studies reported that ret-
inal diseases such as retinitis pigmentosa and choroider-
emia could affect the intraocular straylight [10–12].
However, these studies concluded that increased stray-
light in these retinal diseases was associated with early
structural changes in the crystalline lens before the de-
velopment of a clinically discernible posterior subcapsu-
lar opacity [12]. As far as we know, no previous study
has described the relationship between intraocular stray-
light and pure retinal disorder.
In diabetic retinopathy (DR), contrast sensitivity (CS)
function is reduced; thus, the CS test has been proven
useful for diagnosing early and advanced DR [13–15].
Besides, CS is known to be significantly impaired in pa-
tients with diabetes mellitus (DM) without definite DR.
Therefore, Katz et al. [16] suggested that the CS test can
be an important tool for detecting early changes before
overt DR occurs. They described that this impairment can
be caused by neuronal damage at the level of photorecep-
tors before expressing clinically detectable microangiopa-
thy in the retina of diabetic patients. As mentioned above,
intraocular straylight can decrease the contrast of per-
ceived images that fall on the retina. Based on the above,
we hypothesized that retinal vascular disorders such as
DR can also increase the intraocular straylight level.
The aim of the present study was to prove the rela-
tionship between the intraocular straylight level and DR
according to disease severity. Additionally, we aimed to
evaluate whether DM per se could be a risk factor of in-
creased intraocular straylight although we did not rely
on a definite sign of DR in this study.
Methods
Subjects
This prospective study involved eyes with cataracts
planned to undergo routine phacoemulsification and
posterior chamber IOL implantation between March
2012 and June 2014. In total, 67 eyes of 67 type 2 dia-
betic patients and 26 eyes of 26 non-diabetic patients
were enrolled in this study. All the patients underwent
detailed ophthalmologic examinations including meas-
urement of best corrected visual acuity (BCVA), intraoc-
ular pressure, slit lamp examination of the anterior
segment, fundus examination, central subfield macular
thickness using optical coherence tomography (Stratus
OCT, Carl Zeiss Meditec, Inc., Dublin, CA), and intraoc-
ular straylight. These examinations were implemented
preoperatively and at 2 months postoperatively.
Medical data were collected for diabetic patients,
including the duration of disease, comorbid medical
disease such as hypertension and hyperlipidemia, fasting
glucose and hemoglobin A1c (HbA1c) level. Ocular con-
ditions that influence the intraocular straylight were ex-
cluded, including glaucoma, corneal opacities, and other
retinal diseases such as definite macular edema on
OCT and uveitis. Cataract surgery consisted of no-
stitch, 2.8-mm clear corneal incision and phacoemulsi-
fication with implantation of an aspheric posterior
chamber IOL (MI60, Bausch & Lomb, Rochester, NY,
USA). This IOL is a hydrophilic acrylic, biconvex an-
terior and posterior aspheric lens with an aberration-
free optic. All the enrolled patients in this study
underwent implantation of this IOL with phacoemulsi-
fication. If the patient underwent cataract surgery on
both eyes, we randomly chose and enrolled only one
eye for this study. None of the patients presented any
characteristics that would be expected to lead to an in-
creased level of postoperative intraocular straylight be-
cause there were no specific complications during the
cataract surgery or follow-up periods.
Before the enrollment in this study, all patients pro-
vided written informed consent in accordance with the
protocol approved by the Helsinki Committee. Addition-
ally, this study was approved by Institutional Review
Board of the Catholic University of Korea.
Division of groups
In this prospective study, 93 eyes were enrolled and di-
vided into four groups. Patients were graded for the
presence or absence and severity of DR according to the
findings observable upon dilated ophthalmoscopy as
shown in Table 1. The four groups were as follows: 26
patients (26 eyes) in Group 1 without DM or DR, 25 pa-
tients (25 eyes) in Group 2 with DM but without DR, 21
diabetic patients (21 eyes) with mild to moderate non-
proliferative diabetic retinopathy (NPDR) in Group 3,
and 21 diabetic patients (21 eyes) with severe NPDR in
Group 4. None of the patients presented obvious
Table 1 Diabetic retinopathy disease severity scale according to
the Early Treatment Diabetic Retinopathy Study (ETDRS)
Mild non-proliferative diabetic retinopathy
Microaneurysms only
Moderate non-proliferative diabetic retinopathy
More than just microaneurysms but less than severe non-proliferative
diabetic retinopathy
Severe non-proliferative diabetic retinopathy
Any of the following:
More than 20 intraretinal hemorrhages in each of four quadrants
Definite venous beading in more than two quadrants
Prominent intraretinal microvascular abnormalities in more than one
quadrant and no signs of proliferative retinopathy
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diabetic macular edema because there was no apparent
retinal thickening or hard exudates in the posterior pole
in the fundus examination and macular OCT analysis.
Measurement of intraocular straylight
Based on the compensation comparison, a straylight
meter (Oculus C-Quant, Oculus GmbH) was used to
measure the level of intraocular straylight (The
Netherlands Royal Academy has a patent with
Thomas Van den Berg inventor licensed to Oculus
GmbH for the C-quant straylight meter). That is, the
straylight meter was used to objectively measure intraocu-
lar straylight preoperatively and 2 months postoperatively
after all patients underwent phacoemulsification surgery.
Briefly, the C-quant measures the level of intraocular
straylight by compensating for the amount of straylight on
a test field, with counter-phase flickering of the test field
of variable intensity. The intensity of the counter-phase
flickering required to compensate for the induced flicker-
ing by the straylight is a measure of the level of intraocular
straylight [17]. Before each measurement, the refractive
correction was carried out, if necessary. The C-quant
straylight meter took measurements in photopic condi-
tions, and measurements were taken in complete darkness
to avoid any light from other sources [18]. When the
measurement was completed, the reliability of the result
was evaluated. The measurement was considered reliable
when standard deviation of the measured straylight
value (Esd) ≤0.08 and reliability coefficient (Q) ≥1. In-
traocular straylight measured in these enrolled pa-
tients was thought to be caused by the DR only
because the effect of lens opacity could be excluded
in these pseudophakic eyes.
Statistical analysis
All data were analyzed using SPSS 12.0 for Windows
statistical software (SPSS, Inc., Chicago, IL, USA),
and expressed as the mean ± standard error (SE).
After the cataract surgery, the BCVA (expressed in a
logMAR scale), HbA1c level, and central subfield
macular thickness among the four groups were ana-
lyzed using one-way analysis of variance (ANOVA).
The intraocular straylight level among the groups was an-
alyzed using analysis of covariance (ANCOVA) for con-
trolling of bias factors, such as age. For pairwise
comparisons, the Bonferroni test was used for post-hoc
analysis, assuming equal variance. Additionally, regression
equations were calculated between intraocular straylight
and age using regression analysis. A P value of <0.05 was
considered statistically significant.
Results
Baseline characteristics of the patients in the four groups
are described in Table 2. There was no statistically
significant difference in preoperative BCVA and pre-
operative intraocular straylight level among the four
groups (P = 0.155, 0.202 respectively, one way ANOVA).
Because we enrolled patients without macular edema in
this study, there was no statistically significant differ-
ence central subfield macular thickness among four
groups (P = 0.128, one way ANOVA): 222.77 ± 2.74 μm,
217.36 ± 2.06 μm, 218.14 ± 2.78 μm, and 225.43 ± 3.28 μm
as mean ± SE.
Before comparing the values of postoperative straylight
among the four groups, we evaluated the factors of co-
variates that influenced the straylight level using tests of
between-subjects effects in ANCOVA. As a result,
HbA1c, duration of diabetes and central macular thick-
ness showed no significant result, and age was the only
covariate that influenced the postoperative intraocular
straylight level (P = 0.540, 0.569, 0.884, and 0.001, re-
spectively, ANCOVA, data not shown). As shown in a
previous study [8], there was a weak positive correlation
between age and intraocular straylight in our pseudo-
phakic eyes (Fig. 1). After adjusting for age, the partial
correlation analysis, between HbA1c and postoperative
straylight level was not significant (r = 0.209, P = 0.092,
partial correlation test, data not shown). Additionally,
there was no correlation between the duration of dia-
betes and postoperative straylight level when adjusting
for age (r = −0.236, P = 0.056, partial correlation test,
data not shown). That is, there was no significant correl-
ation between HbA1c level, duration of diabetes and
postoperative straylight level.
The value of estimated marginal means of postopera-
tive intraocular straylight which was corrected for differ-
ences in age between subgroups showed a significant
difference among the four groups (P <0.001, ANCOVA).
The means and linear regression equation are demon-
strated in Table 3 and Fig. 2. The post hoc analysis was
conducted among the four groups by implementing pair-
wise comparison using Bonferroni analysis. As a result,
Group 4 showed the highest level of postoperative stray-
light compared with the other three groups. Group 3
showed highest straylight level when compared with
Groups 1 and 2. Group 2, that is, DM patients without
DR showed higher straylight level than Group 1, that is,
patients without DM (Table 4).
Discussion
The natural human crystalline lens and iris can be im-
portant sources of light scattering [2]. Therefore, if the
crystalline lens is replaced with a clear IOL during cata-
ract surgery, the new lens may become a source of light
scattering. Assuming an IOL is made of nearly perfectly
clear material, we could theoretically exclude the effect
of lens opacity on light scattering. Intraocular straylight
was measured with normal pupillary size of roughly 2 to
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7 mm in diameter under low photopic conditions, to ex-
clude the effect of the iris on the amount of straylight
measured. Additionally, straylight is strongly correlated
with age and is known to increases rapidly after the age
of 50 years in the normal population [19]. Thus, we ana-
lyzed the effect of DR on the straylight using the
ANCOVA test to exclude the bias of age.
We found that a significant impairment of the intraoc-
ular straylight was revealed as the severity of DR in-
creased in this study. Interestingly, this impairment of
straylight was also applied in the diabetic patients even
though they did not present definite DR in the test of di-
lated ophthalmoscopy. However, in our study, there was
no correlation between intraocular straylight level and
HbA1c. This means that the degree of glycemic control
did not affect the amount of intraocular straylight. The
Early Treatment Diabetic Retinopathy Study (ETDRS)
identified important risk factors of the progression to
high-risk proliferative diabetic retinopathy (PDR), in-
cluding retinopathy severity, decreased visual acuity,
high levels of HbA1c and serum lipids level [20]. That is,
a poor control of DM influences the progression of DR.
However, this point was not supported by our findings
because there was no significant difference in HbA1c
levels among Groups 2, 3, and 4. We assumed that this
occurred because only patients with NPDR were en-
rolled in this study. If the patients with PDR and CSME
would have been enrolled in this study, perhaps we
Table 2 Baseline characteristics of the four groups
Group 1 (26 eyes) Group 2 (25 eyes) Group 3 (21 eyes) Group 4 (21 eyes)
Age (years) 68.96 ± 1.40 (55–79) 71.40 ± 1.18 (57–82) 60.91 ± 1.61 (45–73) 63.95 ± 1.80 (51–77)
HbA1c (%) - 6.67 ± 0.14 (5.90–8.20) 6.40 ± 0.13 (5.20–8.10) 6.99 ± 0.18 (5.80–8.70)
Duration of DM (years) - 22.69 ± 1.18 (13–34) 13.86 ± 1.02 (5–21) 16.10 ± 0.87 (8–23)
Central macular thickness (μm) 222.77 ± 2.74 (189–242) 217.36 ± 2.06 (197–241) 218.14 ± 2.78 (198–242) 225.43 ± 3.28 (198–250)
Preoperative straylight (log(s)) 2.08 ± 0.05 (1.56–2.37) 2.18 ± 0.04 (1.65–2.35) 2.19 ± 0.04 (1.48–2.36) 2.13 ± 0.04 (1.56–2.36)
Preoperative BCVA (LogMAR) 0.48 ± 0.04 (0.20–0.90) 0.48 ± 0.03 (0.30–0.70) 0.56 ± 0.05 (0.20–1.00) 0.58 ± 0.04 (0.30–1.00)
Postoperative straylight (log(s)) 1.21 ± 0.04 (0.68–1.43) 1.44 ± 0.06 (1.14–2.03) 1.45 ± 0.03 (1.19–1.69) 1.70 ± 0.09 (1.16–2.24)
Postoperative BCVA (LogMAR) 0.08 ± 0.01 (0.00–0.18) 0.10 ± 0.01 (0.00–0.18) 0.10 ± 0.02 (0.00–0.18) 0.14 ± 0.02 (0.00–0.30)
Data in the table are presented as means ± standard errors
HbA1c = hemoglobin A1c, DM = diabetes mellitus, BCVA = best corrected visual acuity
Fig. 1 Linear regression analysis of the measured straylight levels in the four groups. The regression analysis showed a weak relationship between
age and straylight level. The equation was as follows: log(s) = 0.790 + age × 0.010 (P = 0.018, R2 = 0.060)
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could have detected a significant difference in the
HbA1c level among the groups. According to our re-
sults, poor glycemic control may not contribute to the
increase of intraocular straylight.
To the best of our knowledge, this study is the first to
investigate the relationship between the severity of DR
and the level of intraocular straylight. However, many
studies have investigated the effect of DR on other visual
functions, such as CS. Previous studies indicated that
abnormal and reduced CS was observed in patients
with DR more frequently than in patients without DR
[14, 21]. These studies suggests that the measurement
of CS could provide a clinical option for further identify-
ing early DR in the patients with DM. Brinchmann-
Hansen et al. also reported that CS of 6 cycles per degree
was associated with the grade of retinopathy, and patients
with retinopathy had reduced visual function compared to
those without [22]. Consistent with the lack of correlation
between straylight and HbA1c in this study, they con-
cluded that reduced CS was not related to glycemic con-
trol, duration of diabetes or urinary albumin excretion.
Katz et al.[16] suggested that mesopic foveal CS is im-
paired in diabetic patients even though they have a good
visual acuity, normal fundus and normal OCT findings.
Table 3 Estimated marginal means adjusted by age with linear regression equation
Group 1 Group 2 Group 3 Group 4
Estimated marginal means 1.162 ± 0.047 1.344 ± 0.050 1.560 ± 0.055 1.756 ± 0.053
95 % confidence interval 1.068–1.255 1.244–1.444 1.450–1.671 1.651–1.860
Multiple linear regression log(s) = −0.174 + age × 0.020 log(s) = −0.079 + age × 0.021 log(s) = 1.011 + age × 0.007 log(s) = −0.097 + age × 0.028
Fig. 2 Linear regression analysis of measured straylight levels according to each group (equations in Table 3). a. Group 1, b. Group 2, c. Group 3,
d. Group 4
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We also concluded that intraocular straylight was in-
creased in the DM patients without definite DR when
compared with the control group. Therefore, we con-
cluded that the measurement of intraocular straylight by
C-quant could be a useful clinical screening tool for de-
tecting early retinal change before overt DR occurs.
Of course, the cause of increased straylight in DR
could not be limited to retinal factors. Diabetic keratopa-
thy could be another complication of diabetes [23] that
can cause increased straylight. Takahashi et al. [24]
proved that light scattering at the corneal basement
membrane increased proportionally with the extent of
DR. Further, Morishige et al. [25] measured the light
scattering of the corneal epithelial basement membrane
in patients with type 2 DM with DR and healthy subjects
and found that the light scattering index was signifi-
cantly higher in patients with DM with PDR compared
with healthy controls. Furthermore, patients with DM
are known to experience vitreous degeneration earlier
than those without DM [26]. Although no previous
study has demonstrated the relationship between dia-
betic vitreopathy and light scattering, factors associated
with the vitreous can affect the optical quality of the eye
[27]. Future studies demonstrating the relationship be-
tween diabetic vitreopathy and intraocular straylight
would be necessary.
We did not evaluate the pupil size before and after
cataract surgery nor its effect on intraocular straylight.
That is, pupil size was not taken into account in this
study. Cataract extraction surgery is known to affect
pupil size and centration [28, 29]. However, none of our
patients had any pupillary abnormalities and their pupils
were within the normal size range after the cataract sur-
gery. In our study, straylight was likely to be measured
in eyes with different pupil sizes. The C-quant was used
under photopic luminance conditions, and thus, the
pupil size always corresponded to photopic pupil size.
However, Franssen et al. [17, 30] reported that in natural
pupils approximately 2–7 mm in diameter, straylight can
be regarded only as weakly dependent on the pupil size
(within 0.02 log units). That is, in pupils within the nor-
mal size range, pupil size has little effect on straylight.
It is not unclear why the intraocular straylight is sig-
nificantly increased in diabetic patients with DR and
without definite DR compared with non-diabetic con-
trols. According to the study by Lopes de Faria et al.
[31], a significant and nonselective neuronal visual loss
involving the visual pathway precedes the ophthalmos-
copically detectable retinopathy in diabetic patients. Fur-
ther, the retinal fundus is known to be a major
contributor to the amount of intraocular straylight [2].
Thus, we hypothesized that this increment of straylight
might be caused by neuronal damage at the level of the
photoreceptors rather than to clinically detectable dia-
betic retinal microvasculopathy. However, further study
would be necessary to evaluate whether the diabetic pa-
tients with increased straylight could be considered at
high risk developing DR.
The correlation between intraocular straylight and CS
still remains to be elucidated. Forward scattered light
projects a veil of light over the retinal image that de-
creases the contrast of the image. This veil of light is
called intraocular straylight [1, 32]. Therefore, increased
straylight indicates a lower CS. However, the decrease in
CS is much smaller than the increase in straylight; a 5-
fold increase in light scattering lowers CS function by
only 20 %. According to Ralph et al. [33], there is a weak
correlation between CS and the amount of intraocular
straylight. Nevertheless, a certain amount of correlation
seems to exist between intraocular straylight and CS.
Therefore, we hypothesized that measuring the straylight
level could be a useful clinical screening tool for detect-
ing early diabetic retinal changes alike the CS. Further
research on larger cohorts should be conducted to inves-
tigate the role of straylight measurement in DR
screening.
Conclusion
The level of intraocular straylight seems to be a sensitive
test for detecting early retinal damage secondary to DM,
in spite of good visual acuity, normal fundus finding and
normal OCT findings. We consider that decreased CS
and light scattering could occur in diabetic patients be-
fore the appearance of retinopathy. Regardless of the
prognostic or diagnostic value of these tests, C-quant
could be a suitable screening tool to detect early changes
before overt DR occurs. Future studies should be con-
ducted to establish the role of the straylight meter for
the screening DM.
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